company Debt to equity (x) = Total debt divided by shareholders’ equities Interest bearing debt to equity (x) = Interest bearing debt divided by shareholder’ equities Interest bearing debt to EBITDA (x
bonds 15 477,256 505,934 -6% Short-term loan from related parties 3 423,813 1,269,364 -200% Short-term loan from other parties 15 - 107,424 -100% Loan from shareholder 3 3,850 3,850 Advances received from
attributed to the Company's Shareholder). (a) Calculation on the basis of NTA Transaction size = NTA of Permata x Percentage of assets acquired x 100 NTA of the Bank = 50,271.91 x 100% x 100 428,385.90 = 11.74
latest financial statements reviewed by an auditor (โปรดเลือก และแนบเอกสารหลักฐานประกอบ / Please select and attach document(s)) □ มีส่วนของผู้ถือหุ้นตั้งแต ่100 ล้านบาทขึ้นไป หรือ / having shareholder
% Short-term loan from related parties 811,362,306 1,269,363,868 -56% Short-term loan from other parties - 107,424,045 -100% Loan from shareholder 3,850,000 3,850,000 0% Advances received from customers
company Debt to equity (x) = Total debt divided by shareholders’ equities Interest bearing debt to equity (x) = Interest bearing debt divided by shareholder’ equities Interest bearing debt to EBITDA (x
Quarter 2020 MD&A 8 IVL Strategic Priorities Going Forward IVL remains focused on its financial objective for 2023 - to achieve double-digit ROCE in each of its core businesses; top decile total shareholder
decile total shareholder returns (TSR) position vs. peers and a strong cash flow through the cycle. As presented at our Capital Markets days in Feb 2020, On the journey to achieve above objectives, IVL is
Siripornpitak and / or The group of Mr. Thongplew Siripornpitak whom of which is currently a shareholder of Modern Pharma Company Limited ("Modern Company") Relationship: No relationship between them because the
shares or be a partner of such juristic person exceed 10 percent of total shares sold or amount of contribution; (d) .Juristic person which shareholder who hold shares or be a partner of such juristic